What is Mizuho's rating on UnitedHealth?

Mizuho has an Outperform rating on the stock.

Why did Mizuho raise the target?

Due to an improving managed care sector outlook and positive earnings expectations.

Is UnitedHealth a recommended dividend stock?

Yes, D. E. Shaw included it among the 10 Best Dividend Stocks to Buy.

Mizuho Raises UnitedHealth (UNH) Target to $460 on Managed Care Optimism

Mizuho raised its price target on UnitedHealth (UNH) to $460 from $440, maintaining an Outperform rating. The move reflects optimism about the managed care sector's improving conditions.

June 10, 2026

2 min read

Source: Insider Monkey

Key Numbers

new target

$460

old target

$440

rating

Outperform

Mizuho raised its price target on UnitedHealth Group (NYSE: UNH) to $460 from $440, reiterating an Outperform rating, according to a report from Insider Monkey. The firm believes the managed care sector is improving, supporting a positive view on the stock.

Rating Change

Previous Target: $440
New Target: $460
Rating: Outperform

Analyst Rationale

Mizuho sees improving operating conditions in the managed care sector, which could boost UnitedHealth's earnings. The company is also listed among the 10 Best Dividend Stocks to Buy according to D. E. Shaw, making it attractive for income-focused investors.

Context

The upgrade follows a strong performance by UnitedHealth in recent months, benefiting from steady demand for healthcare services. Other analysts have mixed views, but Mizuho stands out as bullish.

What to Make of It

The target increase reflects Mizuho's confidence in UnitedHealth's growth amid sector improvement. However, investors should weigh risks from healthcare regulations and market conditions before making decisions.

Frequently Asked Questions

Mizuho raised its price target to $460 from $440.

Found this useful? Share it

This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.